GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$0.570
-0.0755 (-11.70%)
At Close: Apr 18, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.500 $0.720 Thursday, 18th Apr 2024 ADXS stock ended at $0.570. This is 11.70% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 14.20% from a day low at $0.500 to a day high of $0.571.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
2020-10-23 $0.485 $0.518 $0.466 $0.509 4 351 217
2020-10-22 $0.510 $0.511 $0.471 $0.492 3 187 444
2020-10-21 $0.460 $0.539 $0.444 $0.511 15 060 250
2020-10-20 $0.460 $0.470 $0.425 $0.460 2 318 935
2020-10-19 $0.412 $0.469 $0.403 $0.460 3 868 059
2020-10-16 $0.419 $0.420 $0.403 $0.406 654 611
2020-10-15 $0.390 $0.424 $0.390 $0.419 1 920 072
2020-10-14 $0.401 $0.405 $0.390 $0.391 666 340
2020-10-13 $0.401 $0.410 $0.395 $0.398 533 909
2020-10-12 $0.429 $0.429 $0.400 $0.402 832 227
2020-10-09 $0.395 $0.419 $0.393 $0.410 790 511
2020-10-08 $0.396 $0.410 $0.393 $0.395 898 237
2020-10-07 $0.400 $0.407 $0.396 $0.398 426 966
2020-10-06 $0.400 $0.410 $0.391 $0.394 682 106
2020-10-05 $0.422 $0.422 $0.395 $0.400 953 209
2020-10-02 $0.387 $0.413 $0.387 $0.409 1 030 082
2020-10-01 $0.415 $0.415 $0.395 $0.396 879 562
2020-09-30 $0.420 $0.450 $0.402 $0.410 1 364 739
2020-09-29 $0.396 $0.451 $0.396 $0.421 6 191 165
2020-09-28 $0.380 $0.404 $0.372 $0.392 1 368 744
2020-09-25 $0.352 $0.399 $0.340 $0.388 2 507 663
2020-09-24 $0.479 $0.483 $0.355 $0.367 9 653 242
2020-09-23 $0.421 $0.425 $0.382 $0.385 1 113 069
2020-09-22 $0.420 $0.428 $0.413 $0.424 709 386
2020-09-21 $0.440 $0.440 $0.402 $0.416 711 012
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Golden Star

Ticker Date Change Price
ITCI Apr 05 12.05% $68.44
AKR Apr 05 0.665% $16.53
SARK Mar 28 16.07% $26.88
ARCC Mar 25 1.04% $20.12
STT Mar 19 0.262% $72.62
GGB Mar 19 0.468% $4.27
CAG Mar 18 7.16% $28.22
JBI Mar 15 1.29% $14.72
MASI Mar 14 3.34% $132.20
CMC Mar 14 5.04% $53.19
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT